Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to $231000.0.

  • Anika Therapeutics' Change in Account Payables rose 10787.32% to $231000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$956000.0, marking a year-over-year increase of 1123.49%. This contributed to the annual value of -$2.5 million for FY2024, which is 2268181.82% down from last year.
  • Latest data reveals that Anika Therapeutics reported Change in Account Payables of $231000.0 as of Q3 2025, which was up 10787.32% from -$1.1 million recorded in Q2 2025.
  • Anika Therapeutics' Change in Account Payables' 5-year high stood at $1.4 million during Q4 2022, with a 5-year trough of -$2.9 million in Q3 2024.
  • Over the past 5 years, Anika Therapeutics' median Change in Account Payables value was -$60000.0 (recorded in 2021), while the average stood at -$130894.7.
  • Its Change in Account Payables has fluctuated over the past 5 years, first soared by 51500.0% in 2022, then crashed by 91172.41% in 2024.
  • Anika Therapeutics' Change in Account Payables (Quarter) stood at -$398000.0 in 2021, then soared by 459.8% to $1.4 million in 2022, then decreased by 8.66% to $1.3 million in 2023, then tumbled by 109.25% to -$121000.0 in 2024, then skyrocketed by 290.91% to $231000.0 in 2025.
  • Its Change in Account Payables was $231000.0 in Q3 2025, compared to -$1.1 million in Q2 2025 and $47000.0 in Q1 2025.